D
Deciphera Pharmaceuticals
A clinical-stage biopharmaceutical company focused on improving the lives of cancer patients by tackling key mechanisms of drug resistance that limit the effectiveness of many cancer therapies
About Deciphera Pharmaceuticals
Deciphera Pharmaceuticals, a member of ONO Group, is a biopharmaceutical company dedicated to discovering, developing, and commercializing new medicines aimed at improving the lives of cancer patients. The company leverages its proprietary switch-control kinase inhibitor platform and extensive expertise in kinase biology to create a broad portfolio of targeted therapies. Deciphera primarily serves the oncology market, focusing on patients with various forms of cancer. The business model revolves around the research and development of novel drugs, followed by clinical trials and regulatory approvals, leading to commercialization. Revenue is generated through the sale of these approved medicines and potential partnerships or licensing agreements with other pharmaceutical companies.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 2003
- Headquarters
- Waltham, United States
- Listing
- IPO 2017
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tierThoroughbred$100M+ revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
New Leaf Venture Partners
SV Health Investors
Series B and later6 investors entered at this stage
Viking Global Investors
Redmile Group
Sphera Funds Management
Sphera Global Healthcare Fund- Deciphera Pharmaceuticals
- SASunesis Advisors
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
111 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Deciphera Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Deciphera Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.